Topical Clobetasol Propionate in the Treatment of Psoriasis: A Review of Newer Formulations

Author： Feldman Steven R.   Yentzer Brad A.  

Publisher： Adis International

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.10, Iss.6, 2009-12, pp. : 397-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Halobetasol Propionate in the Treatment of Plaque Psoriasis: A Review

By Rivera Allison M.   Hsu Sylvia  

American Journal of Clinical Dermatology, Vol. 6, Iss. 5, 2005-01 ,pp. : 311-316

Adis International

Access to resources Recommend Favorite

Topical Tazarotene: A Review of its Use in the Treatment of Plaque Psoriasis

By Dando Toni M.   Wellington Keri  

American Journal of Clinical Dermatology, Vol. 6, Iss. 4, 2005-01 ,pp. : 255-272

Adis International

Access to resources Recommend Favorite

Clobetasol Propionate Foam, 0.05%

By Melian E.B.   Spencer C.M.   Jarvis B.  

American Journal of Clinical Dermatology, Vol. 2, Iss. 2, 2001-02 ,pp. : 89-92

Adis International

Access to resources Recommend Favorite

The Potential of Newer Immunomodulating Drugs in the Treatment of Uveitis: A Review

By Salzmann J.   Lightman S.  

BioDrugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 397-408

Adis International

Access to resources Recommend Favorite

Clobetasol Propionate Foam, 0.05%: A Viewpoint by Mark Lebwohl and Amy Krupnick

By Lebwohl M.  

American Journal of Clinical Dermatology, Vol. 2, Iss. 2, 2001-02 ,pp. : 93-93

Adis International

Access to resources Recommend Favorite